JOVSKorean-built multi-wavelength LED face maskEvidence-based assessment
JOVS DPL Photofacial Mask review
Updated 2026-10-10
6.8
/ 10
Seven wavelength modes (maker spec) at a mid-tier price — Korean K-beauty tech. Limited clinical evidence; brand newer than category references.Best for users wanting maximum wavelength coverage at mid-tier pricing — spec maximalism over Western clinical-evidence credentials.
JOVS DPL Photofacial Mask is the K-beauty multi-wavelength entry — seven wavelength modes (red, blue, amber, green and more), hard-shell hybrid build, $399 pricing. Brand recognised in K-beauty / Asian skincare market but newer in Western consumer red light category. Spec maximalism over clinical-evidence depth.
How we tested: Evidence-based assessment — scored from JOVS product documentation, the brand’s FDA-registration statement and 2026 K-beauty / Western consumer reviews. Not hands-on tested by ONDA.
Documented irradiance per mode. Less independently verified than category references; spec sheets emphasize peak rather than continuous output.
Wavelength coverage
8.5
Seven wavelength modes (as reviewed). Stated purposes per retail copy: uneven tone, redness and pigmentation, plus wrinkles and acne — JOVS's own product page could not be reached (2026-10-13); re-check. Counted as covering wrinkles (red / near-infrared) and acne (blue / red); extra modes add no score.
LED count and facial coverage
7.0
Solid LED count across hard-shell coverage. No neck flap.
Clinical evidence and regulatory standing
5.5
FDA registered (a listing, not clearance or approval). 510(k) K261851 covers the OEM’s LED masks JML1–JML10; whether the DPL mask is included is not visible in the FDA database. Strong K-beauty consumer market but limited Western peer-reviewed validation on the specific device.
Comfort and wearable fit
6.5
Hard-shell hybrid build — less comfortable than full silicone alternatives. Korean ergonomic design tries to soften the hard form factor.
Value
7.5
$399 — accessible mid-tier pricing for the multi-wavelength spec. Strong per-wavelength cost.
Pros
+Seven wavelength modes (maker spec)
+Accessible $399 pricing for the multi-wavelength spec
+K-beauty engineering pedigree
+Multiple session modes for different indications
Cons
−Light Western clinical-evidence base
−Hard-shell hybrid less comfortable than silicone
−No neck flap
−Newer brand in Western market without multi-year track record
Price: $399 DPL Photofacial Mask standalone (as of 2026-05-28)
Where it leads
JOVS DPL Photofacial Mask is the K-beauty multi-wavelength entry — seven wavelength modes (red, blue, amber, green and more), accessible $399 pricing, Korean engineering pedigree. Seven wavelength modes (maker spec).
What are the downsides of JOVS DPL Photofacial Mask?
Western clinical evidence and comfort. JOVS has K-beauty market credibility but limited Western peer-reviewed validation on the specific device. Hard-shell hybrid build is less comfortable than full silicone alternatives.
Who should buy JOVS DPL Photofacial Mask?
Choose JOVS DPL for maximum wavelength coverage at mid-tier pricing. For a red + near-infrared silicone mask, Omnilux Contour Face. For consumer market leader silicone, CurrentBody Series 2. For dermatology-brand dual-spectrum, Dr. Dennis Gross.
The JOVS DPL Photofacial Mask has seven wavelength modes, including red, blue, amber and green (maker spec). It also offers multiple session modes for different indications, all at a $399 price.
Who is the JOVS DPL Photofacial Mask best for?
It suits buyers who want maximum wavelength coverage at mid-tier pricing and value spec over Western clinical credentials. It brings K-beauty engineering and seven modes for $399. Buyers who prioritise comfort or clinical evidence may prefer silicone masks or brands with a longer Western track record.
What are the downsides of the JOVS DPL Photofacial Mask?
Its Western clinical-evidence base is light, and its hard-shell hybrid build is less comfortable than silicone masks. There is no neck flap. JOVS is recognised in K-beauty but newer in the Western red-light market, without a multi-year track record there.
